SGH
PODD icon

Schonfeld Group Holdings’s Insulet PODD Stock Holding History

Schonfeld Group Holdings’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,400
Closed -$351K – 268
2014
Q1 		$351K Buy
+7,400
New +$327K 0.09% 331

Other funds holding PODD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schonfeld Group Holdings's PODD Position: Q2 2014 in Review

Schonfeld Group Holdings sold out of Insulet (PODD) in Q2 2014, closing a stake of 7,400 shares — an estimated $351K sold.

Schonfeld Group Holdings first reported a position in PODD in Q1 2014 and held it in 1 quarter. The position peaked at $351K in Q1 2014. 175 funds tracked by Wall St. Rank hold PODD as of Q2 2014.

  • Schonfeld Group Holdings reported no remaining Insulet position as of Q2 2014 after selling out during the quarter.
  • Schonfeld Group Holdings sold 7,400 Insulet shares in Q2 2014, an estimated $351K.
  • Schonfeld Group Holdings first reported a position in Insulet in Q1 2014 and held it in 1 quarter.
  • Schonfeld Group Holdings's Insulet position peaked at $351K in Q1 2014.
  • 175 funds tracked by Wall St. Rank held Insulet as of Q2 2014.

Based on Schonfeld Group Holdings's 13F filing for Q2 2014, filed 15 Aug 2014.